Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology

  • Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy: A Systematic Review and Metaanalysis
    You have access
    Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy: A Systematic Review and Metaanalysis
    Arnoldo Piccardo, Pierpaolo Trimboli, Gianluca Bottoni and Luca Giovanella
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1730-1735; DOI: https://doi.org/10.2967/jnumed.120.244384
  • MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of <sup>68</sup>Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
    You have access
    MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
    Leonhard Gruber, Luis David Jiménez-Franco, Clemens Decristoforo, Christian Uprimny, Gerhard Glatting, Peter Hohenberger, Stefan O. Schoenberg, Wolfgang Reindl, Francesca Orlandi, Maurizio Mariani, Werner Jaschke and Irene Virgolini
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1749-1755; DOI: https://doi.org/10.2967/jnumed.119.238808
  • Open Access
    Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PET
    Rohini Sharma, Marianna Inglese, Suraiya Dubash, Haonan Lu, David J. Pinato, Chandan Sanghera, Neva Patel, Anthony Chung, Paul D. Tait, Francesco Mauri, William R. Crum, Tara D. Barwick and Eric O. Aboagye
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1743-1748; DOI: https://doi.org/10.2967/jnumed.119.240598
  • You have access
    NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with 90Y Resin Microspheres Versus Sorafenib in Advanced Hepatocellular Carcinoma
    Marino Venerito, Maciej Pech, Ali Canbay, Rossella Donghia, Vito Guerra, Gilles Chatellier, Helena Pereira, Mihir Gandhi, Peter Malfertheiner, Pierce K.H. Chow, Valérie Vilgrain, Jens Ricke and Gioacchino Leandro
    Journal of Nuclear Medicine December 1, 2020, 61 (12) 1736-1742; DOI: https://doi.org/10.2967/jnumed.120.242933
  • First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
    You have access
    First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
    Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael J. Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley J. Beattie, Pat Zanzonico, Wolfgang A. Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson and Mark P.S. Dunphy
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1580-1587; DOI: https://doi.org/10.2967/jnumed.119.234864
  • <sup>18</sup>F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume
    You have access
    18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume
    James C. Reynolds, Roberto Maass-Moreno, Anish Thomas, Alexander Ling, Emerson B. Padiernos, Seth M. Steinberg and Raffit Hassan
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1570-1575; DOI: https://doi.org/10.2967/jnumed.119.238733
  • You have access
    PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer
    Tahleesa J. Cuda, Andrew D. Riddell, Cheng Liu, Vicki L. Whitehall, Jennifer Borowsky, David K. Wyld, Matthew E. Burge, Elizabeth Ahern, Alison Griffin, Nicholas J.R. Lyons, Stephen E. Rose, David A. Clark, Andrew R.L. Stevenson, John D. Hooper, Simon Puttick and Paul A. Thomas
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1576-1579; DOI: https://doi.org/10.2967/jnumed.119.233312
  • Open Access
    Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
    Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Patricia Bronkhorst, Sanne A.M. van Lith, Maarten Brom, Mijke Buitinga and Martin Gotthardt
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1588-1593; DOI: https://doi.org/10.2967/jnumed.119.238998
  • Prognostic Value of <sup>18</sup>F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy
    You have access
    Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy
    Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni and Richard P. Baum
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1560-1569; DOI: https://doi.org/10.2967/jnumed.119.241414
  • The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    You have access
    The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1594-1601; DOI: https://doi.org/10.2967/jnumed.120.241877

Pages

  • Previous
  • Next
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 45
SNMMI

© 2025 SNMMI

Powered by HighWire